Cargando…
Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment
The International System for Reporting Serous Fluid Cytopathology (TIS) classifies serous effusions into five categories: non-diagnostic (ND), negative for malignancy (NFM), atypia of unknown significance (AUS), suspicious for malignancy (SFM) and malignant (MAL). The main objectives of this classif...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700584/ https://www.ncbi.nlm.nih.gov/pubmed/34943460 http://dx.doi.org/10.3390/diagnostics11122223 |
_version_ | 1784620792356536320 |
---|---|
author | Pergaris, Alexandros Stefanou, Dimitra Keramari, Panagiota Sousouris, Stylianos Kavantzas, Nikolaos Gogas, Helen Mikou, Panagiota |
author_facet | Pergaris, Alexandros Stefanou, Dimitra Keramari, Panagiota Sousouris, Stylianos Kavantzas, Nikolaos Gogas, Helen Mikou, Panagiota |
author_sort | Pergaris, Alexandros |
collection | PubMed |
description | The International System for Reporting Serous Fluid Cytopathology (TIS) classifies serous effusions into five categories: non-diagnostic (ND), negative for malignancy (NFM), atypia of unknown significance (AUS), suspicious for malignancy (SFM) and malignant (MAL). The main objectives of this classification comprise the establishment of a universal code of communication between cytopathologists and clinicians and histopathologists, as well as between different laboratories worldwide, paving the way for the setting of clinical management guidelines based on the risk of malignancy assessment for each diagnostic category. We retrieved the total number of pleural and peritoneal effusion cases of our department for the three-year time period between 2018 and 2020, yielding a total of 528 and 500 cases, respectively. We then proceeded to reclassify each specimen according to TIS guidelines and calculate the risk of malignancy (ROM) for each category by searching each patients’ histology records, medical history and clinical follow-up. For pleural effusions, 3 (0.57%) cases were classified as ND, 430 (81.44%) cases as NFM, 15 (2.84%) as AUS, 15 (2.84%) as SFM and 65 (12.31%) as MAL. ROM amounted to 0%, 5.3%, 33.33%, 93.33% and 100% for each category, respectively. As far as peritoneal effusions are concerned, 6 (1.2%) were categorized as ND with ROM estimated at 16.66%, 347 (69.4%) as NFM (ROM = 9%), 13 (2.6%) as AUS (ROM = 38.46%), 12 (2.4%) as SFM (ROM = 83.33%) and 122 (24.4%) as MAL (ROM = 100%). Our results underline the utility of the current classification, both as a means of communication between doctors of different specialties and as general guidelines for the further clinical management of patients. |
format | Online Article Text |
id | pubmed-8700584 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87005842021-12-24 Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment Pergaris, Alexandros Stefanou, Dimitra Keramari, Panagiota Sousouris, Stylianos Kavantzas, Nikolaos Gogas, Helen Mikou, Panagiota Diagnostics (Basel) Article The International System for Reporting Serous Fluid Cytopathology (TIS) classifies serous effusions into five categories: non-diagnostic (ND), negative for malignancy (NFM), atypia of unknown significance (AUS), suspicious for malignancy (SFM) and malignant (MAL). The main objectives of this classification comprise the establishment of a universal code of communication between cytopathologists and clinicians and histopathologists, as well as between different laboratories worldwide, paving the way for the setting of clinical management guidelines based on the risk of malignancy assessment for each diagnostic category. We retrieved the total number of pleural and peritoneal effusion cases of our department for the three-year time period between 2018 and 2020, yielding a total of 528 and 500 cases, respectively. We then proceeded to reclassify each specimen according to TIS guidelines and calculate the risk of malignancy (ROM) for each category by searching each patients’ histology records, medical history and clinical follow-up. For pleural effusions, 3 (0.57%) cases were classified as ND, 430 (81.44%) cases as NFM, 15 (2.84%) as AUS, 15 (2.84%) as SFM and 65 (12.31%) as MAL. ROM amounted to 0%, 5.3%, 33.33%, 93.33% and 100% for each category, respectively. As far as peritoneal effusions are concerned, 6 (1.2%) were categorized as ND with ROM estimated at 16.66%, 347 (69.4%) as NFM (ROM = 9%), 13 (2.6%) as AUS (ROM = 38.46%), 12 (2.4%) as SFM (ROM = 83.33%) and 122 (24.4%) as MAL (ROM = 100%). Our results underline the utility of the current classification, both as a means of communication between doctors of different specialties and as general guidelines for the further clinical management of patients. MDPI 2021-11-28 /pmc/articles/PMC8700584/ /pubmed/34943460 http://dx.doi.org/10.3390/diagnostics11122223 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pergaris, Alexandros Stefanou, Dimitra Keramari, Panagiota Sousouris, Stylianos Kavantzas, Nikolaos Gogas, Helen Mikou, Panagiota Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment |
title | Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment |
title_full | Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment |
title_fullStr | Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment |
title_full_unstemmed | Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment |
title_short | Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment |
title_sort | application of the international system for reporting serous fluid cytopathology with cytohistological correlation and risk of malignancy assessment |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700584/ https://www.ncbi.nlm.nih.gov/pubmed/34943460 http://dx.doi.org/10.3390/diagnostics11122223 |
work_keys_str_mv | AT pergarisalexandros applicationoftheinternationalsystemforreportingserousfluidcytopathologywithcytohistologicalcorrelationandriskofmalignancyassessment AT stefanoudimitra applicationoftheinternationalsystemforreportingserousfluidcytopathologywithcytohistologicalcorrelationandriskofmalignancyassessment AT keramaripanagiota applicationoftheinternationalsystemforreportingserousfluidcytopathologywithcytohistologicalcorrelationandriskofmalignancyassessment AT sousourisstylianos applicationoftheinternationalsystemforreportingserousfluidcytopathologywithcytohistologicalcorrelationandriskofmalignancyassessment AT kavantzasnikolaos applicationoftheinternationalsystemforreportingserousfluidcytopathologywithcytohistologicalcorrelationandriskofmalignancyassessment AT gogashelen applicationoftheinternationalsystemforreportingserousfluidcytopathologywithcytohistologicalcorrelationandriskofmalignancyassessment AT mikoupanagiota applicationoftheinternationalsystemforreportingserousfluidcytopathologywithcytohistologicalcorrelationandriskofmalignancyassessment |